ArticleOncoTargets and therapy2020

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study.

Qian Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.